Summary
Dalya Gartzman is a mathematician-turned-AI entrepreneur with nine years of experience building production-ready algorithms and leading AI initiatives across early-stage startups. As co-founder and CEO she’s translated deep technical work—spanning bioinformatics, deep learning, computer vision and optimization—into product-focused ventures including Renasis Bio, an AI-driven small-molecule drug discovery platform targeting RNA. Her background blends rigorous academic research in algorithms and biological networks with hands-on engineering leadership at companies like Via, SiteAware and Quay, where she moved proofs-of-concept into commercial systems. A committed community builder and mentor, she’s also led outreach projects for women in tech and healthcare, and even hosts a startup podcast documenting her founder journey. Notably, she pairs theoretical insight (MSc in Mathematics) with pragmatic naming discipline—“gives meaningful names to variables”—reflecting a rare attention to clarity across code, research and product.
9 years of coding experience
6 years of employment as a software developer
Master of Science (MSc) Mathematics, Master of Science (MSc) Mathematics at Tel Aviv University
Hebrew, English